Allogene Therapeutics Inc. Intrinsic Value

ALLO

Allogene Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Allogene Therapeutics today, so there is nothing to project yet.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ALLO

CompareIntrinsic value

ATRAAtara Biotherapeutics, Inc.

$8.37+2.07%15

ELOXEloxx Pharmaceuticals, Inc.

$12.74-1.39%20

CCCCC4 Therapeutics Inc.

$3.12-2.80%33

AUTLAutolus Therapeutics plc

$1.38-2.83%40

TSHATaysha Gene Therapies Inc.

$4.36+6.60%40

CRDFCardiff Oncology Inc.

$0.87+1.03%36

LENZLENZ Therapeutics, Inc.

$3.46-1.14%10

PROKProKidney Corp

$1.12+4.67%10

Held by ETFs

ALLO is in 22 US ETFs. The largest of them, with ALLO's weight in each:

Spot a number that looks wrong? Check it in ALLO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALLO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.